USP7 depletion or pharmacological inhibition by P22077 treatment in melanoma or murine (B16) cell lines has been shown to alter tumor expansion in vivo, cell proliferation in vitro, and migration and invasion [49,50,51]. The gene discussed is USP7; the disease is melanoma.